Metabolic surgery for type-2-diabetes within BMI range of 27 to 60 kg/sqm (MetaSurg) (Prof. Dr. Arne Dietrich)
Obese patients often suffer from type 2 diabetes. They benefit especially from bariatric surgery, because after the intervention the diabetes usually improves considerably or even recedes completely (remission). The most common obesity (bariatric) surgery is the gastric bypass (Roux-en-Y Gastric Bypass, RYGB). In the MetaSurg study the surgical results of the RYGB operations with different lengths of the digesting intestinal loops are being compared. Additionally there is a conservative control group.
The intestinal tube is inserted with the help of an endoscope and lines a part of the duodenum and small intestine, where it prevents the digestion of food and thus leads to a long-term weight loss and thus also to an improvement of the metabolism. Study participants will be supervised over eight years. The long-term medical- and cost-effectiveness of the two interventions will be be clarified.
Duration: 01.01.2016 - 30.04.2020
Description of research project